NCT02739906 - A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

BioChaperone Human Insulin (HinsBet®)

BioChaperone Human Insulin (HinsBet®) individualised single subcutaneous injection followed by test meal intake

DRUG

Insulin Lispro (Humalog®)

Insulin Lispro (Humalog®) individualised single subcutaneous injection followed by test meal intake

DRUG

Regular human insulin (Huminsulin® Normal)

Regular human insulin (Huminsulin® Normal) individualised single subcutaneous injection followed by test meal intake

Trial Locations (2)

Profil GmbH, Neuss

Profil Mainz GmbH & Co.KG, Mainz